Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR | 17 | 1 | 3 | 0 | €119.00 | €130.44 | 9.612% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €91.85 | €99.50 | 8.329% |
| Cocrystal Pharma Inc. | 6 | 0 | 1 | 0 | €1.38 | €10.08 | 630.290% |
| Celldex Therapeutics | 9 | 1 | 0 | 0 | €34.00 | €51.20 | 50.581% |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €86.92 | - | - |
| Sensorion SA | 2 | 0 | 0 | 0 | €0.66 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €342.00 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €42.40 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 2 | 0 | €4.32 | €5.00 | 15.741% |
| Cellectar BioSciences Inc. | 7 | 9 | 0 | 1 | €2.84 | €10.55 | 271.331% |
| ImmunityBio Inc. | 3 | 0 | 1 | 0 | €6.87 | €10.00 | 45.645% |
| Teva Pharmaceutical Industries Ltd ADR | 11 | 0 | 0 | 0 | €12.95 | €13.50 | 4.247% |
| Icon plc | 18 | 0 | 6 | 0 | €288.20 | €318.99 | 10.685% |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.81 | - | - |
| Biogen Inc. | 44 | 2 | 4 | 1 | €195.30 | €294.45 | 50.767% |
| Amgen Inc. | 22 | 0 | 3 | 0 | €252.35 | €294.28 | 16.617% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.46 | €4.00 | 62.602% |
| Deciphera Pharmaceuticals | 6 | 0 | 1 | 0 | €13.30 | €21.53 | 61.874% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €84.80 | €100.00 | 17.925% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €2.99 | - | - |
| Geron Corp. | 10 | 0 | 2 | 0 | €3.54 | €4.59 | 29.867% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €212.30 | €247.61 | 16.631% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.94 | €26.01 | 18.534% |